Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Deep Vein Thrombosis Global Market Report 2025
Download Free Sample Buy Now
Global Deep Vein Thrombosis Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Deep Vein Thrombosis Global Market Report 2025

By Drug Class (Anticoagulants, Inferior Vena Cava Filters, Other Drug Class), By Treatment (Surgery, Drugs, Other Treatments), By Mode Of Administration (Injectable, Oral, Other Modes Of Action), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospitals, Homecare, Specialty Clinics, Other End-users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Deep Vein Thrombosis Market Overview

• Deep Vein Thrombosis market size has reached to $1.06 billion in 2024

• Expected to grow to $1.3 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%

• Growth Driver: Rising Demand For Deep Vein Thrombosis (DVT) Treatment Drives Market Growth

• Market Trend: Companies Unveil Revolutionary Mechanical Thrombectomy System With Lightning Flash Technology To Driving Innovations In Deep Vein Thrombosis Market

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Deep Vein Thrombosis Market?

Deep vein thrombosis (DVT) refers to a serious medical condition that occurs when a blood clot forms in one or more of the deep veins in the body. The symptoms of DVT can include swelling, pain, and tenderness in the affected area, usually the leg.

The main types of drugs used to treat deep vein thrombosis are anticoagulants, inferior vena cava filters, and others. Anticoagulants, also known as blood thinners, are medications that are used to prevent blood clots from forming in the blood vessels. It is treated by surgery, drugs, and others and various modes of administration are included, such as injectable, oral, and others. These are sold through several distribution channels, such as hospital pharmacies, retail pharmacies, and online pharmacies, and are used by various end-users, including hospitals, homecare, specialty clinics, and others.

Deep Vein Thrombosis Market Size and growth rate 2025 to 2029: Graph

What Is The Deep Vein Thrombosis Market Size 2025 And Growth Rate?

The deep vein thrombosis market size has grown steadily in recent years. It will grow from$1.06 billion in 2024 to $1.09 billion in 2025 at a compound annual growth rate (CAGR) of 3.1%. The growth in the historic period can be attributed to increased vascular medicine specialization, influence of medical guidelines, focus on thrombosis prevention, clinical research development, increased diagnosis awareness

What Is The Deep Vein Thrombosis Market Growth Forecast?

The deep vein thrombosis market size is expected to see steady growth in the next few years. It will grow to $1.3 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to growing aging population, rising incidence of lifestyle diseases, preventive healthcare emphasis, innovative therapies, focus on patient-centric care. Major trends in the forecast period include risk factors awareness, advancements in diagnosis, treatment innovations, public health initiatives, post-surgical prevention.

The forecast of 4.4% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. vascular medicine departments by inflating prices of direct oral anticoagulants for deep vein thrombosis prophylaxis sourced from Germany and Japan, resulting in compromised thrombosis prevention and higher cardiovascular care costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Deep Vein Thrombosis Market Segmented?

1) By Drug Class: Anticoagulants, Inferior Vena Cava Filters, Other Drug Class

2) By Treatment: Surgery, Drugs, Other Treatments

3) By Mode Of Administration: Injectable, Oral, Other Modes Of Action

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-users

Subsegments:

1) By Anticoagulants: Direct Oral Anticoagulants (DOACs), Vitamin K Antagonists, Low Molecular Weight Heparins, Unfractionated Heparin

2) By Inferior Vena Cava Filters: Retrievable IVC Filters, Permanent IVC Filters, Advanced IVC Filter Systems

3) By Other Drug Class: Thrombolytics, Antiplatelet Agents, Fibrinolytics, Combination Therapy

What Is Driving The Deep Vein Thrombosis Market? Rising Demand For Deep Vein Thrombosis (DVT) Treatment Drives Market Growth

The increasing number of individuals who require deep vein thrombosis (DVT) treatment is expected to propel the growth of the deep vein thrombosis market going forward. DVT treatment refers to treating patients with deep vein thrombosis using drugs such as anticoagulants and others that prevent the formation of new blood clots and existing blood clots from getting larger, alleviating the disease condition. The increase in the number of patients requiring DVT treatment indicates an increase in the prevalence of deep vein thrombosis that requires products for DVT diagnosis, prevention, and treatment. For instance, in February 2023, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, an overall 900,000 people could be affected each year in the United States due to deep vein thrombosis, and between 60,000 and 100,000 Americans die each year from DVT or PE (pulmonary embolism). Therefore, the increasing number of individuals requiring deep vein thrombosis (DVT) treatment is driving the market.

What Is Driving The Deep Vein Thrombosis Market? Rising Obesity Rates Propel Demand For Deep Vein Thrombosis (DVT) Treatment Driving Market Growth

The increasing prevalence of obesity is expected to propel the growth of the deep vein thrombosis market going forward. Obesity is a medical condition characterized by the accumulation of excess body fat, which can lead to various health problems and complications. Deep vein thrombosis (DVT) treatment plays a significant role in managing obesity, as obesity is an independent and moderate risk factor for venous thromboembolism (VTE), which includes DVT and pulmonary embolism (PE). For instance, in March 2023, according to the World Heart Federation, a Switzerland-based non-government global cardiovascular community, globally around 2.3 billion adults and children are obese or overweight, and with the current obesity trend, it is estimated that the number of people living with obesity will reach 2.7 billion by 2025. Therefore, the increasing prevalence of obesity is driving the growth of the deep vein thrombosis industry.

Who Are The Major Players In The Global Deep Vein Thrombosis Market?

Major companies operating in the deep vein thrombosis market include Abbott Laboratories, Bristol-Myers Squibb Company, Sanofi-Aventis U.S. LLC, Daiichi Sankyo Company Limited, Aspen Pharmacare Holdings Limited, Novartis AG, Mylan N.V., Bayer AG, Boehringer Ingelheim GmbH, Medtronic PLC, Hikma Pharmaceuticals PLC, Laboratorios Farmacéuticos Rovi S.A., Cardinal Health Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca PLC, Stryker Corporation, Cook Medical Incorporated, Boston Scientific Corporation, Arjo AB, DJO Global Inc., Zimmer Biomet Holdings Inc., Devon Medical Products LLC, ThermoTek USA Inc., Pfizer Inc.

What Are The Key Trends Of The Global Deep Vein Thrombosis Market? Companies Unveil Revolutionary Mechanical Thrombectomy System With Lightning Flash Technology To Driving Innovations In Deep Vein Thrombosis Market

Product innovations are a key trend gaining popularity in the deep vein thrombosis market. Major companies operating in the deep vein thrombosis market are adopting new technologies to develop new product and to sustain their position in the market. For instance, in January 2023, Penumbra Inc., a US-based developer of innovative therapies, launched Lightning Flash, an advanced and powerful mechanical thrombectomy system for addressing venous and pulmonary thrombus. The system features Penumbra's novel lightning-intelligent aspiration technology and innovative dual clot detection algorithms. It is designed to quickly remove large blood clots in the body, including venous thrombus and pulmonary emboli (PE). It provides physicians with a high torque-able, larger catheter designed for efficiently removing a significant clot burden in the pulmonary arteries or deep venous system while maintaining an excellent safety profile.

What Are The Key Trends Of The Global Deep Vein Thrombosis Market? Thinksono And Nyu Langone Health Partner To Advance Ai-Powered Ultrasound For Deep Vein Thrombosis Diagnosis

Major companies operating in the deep vein thrombosis market are focused on adopting strategic partnerships to enable quick diagnosis of deep vein thrombosis (DVT) and maximize their profits in the market. Such collaborations reflect the growing interest in leveraging AI and machine learning to improve medical diagnostics, including the rapid and precise identification of DVT. For instance, in November 2023, ThinkSono Ltd., a UK-based ultrasound AI company to diagnose deep vein thrombosis, partnered with NYU Langone Health, a US-based academic medical center, to launch the first clinical trial of a new artificial intelligence (AI)-powered ultrasound software that enables more rapid and portable diagnosis of deep vein thrombosis (DVT). Through this partnership, the ThinkSono Guidance System technology utilizes the power of AI to potentially detect DVT more rapidly, precisely, and affordably compared to conventional techniques. In patients with and without DVT, researchers will use the ThinkSono Guidance System in addition to standard ultrasound scanning. To evaluate and confirm the ThinkSono system's accuracy, the two approaches' performances will be contrasted. As part of the school's practical research curriculum, medical students from the NYU Grossman School of Medicine will also assist in running the trial.

Need data on a specific region in this market?
Request Regional Data

Deep Vein Thrombosis Market Merger And Acquisition: Pfizer And Bristol-Myers Squibb Collaborate To Advance Anticoagulation Education

In March 2024, Pfizer Inc., a US-based a biopharmaceutical company, partnerhsed with Bristol-Myers Squibb (BMS) to provide grant support for continuing professional education in the areas of anticoagulation in atrial fibrillation and venous thromboembolism. This partnership encourages organizations to apply for grants aimed at supporting independent education initiatives that improve the understanding of oral anticoagulant treatments for patients with atrial fibrillation and venous thromboembolism. Bristol-Myers Squibb company is a US-based pharmaceutical company.

Regional Analysis For The Global Deep Vein Thrombosis Market

North America was the largest region in the deep vein thrombosis market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global deep vein thrombosis market report during the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Deep Vein Thrombosis Market?

The deep vein thrombosis market includes revenues earned by entities by providing services related to treatment such as blood thinning medication, thrombolytic therapy, interventional radiology therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Deep Vein Thrombosis Industry?

The deep vein thrombosis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the deep vein thrombosis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Deep Vein Thrombosis Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $1.09 billion
Revenue Forecast In 2034 $1.3 billion
Growth Rate CAGR of 4.4% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Drug Class: Anticoagulants, Inferior Vena Cava Filters, Other Drug Class
2) By Treatment: Surgery, Drugs, Other Treatments
3) By Mode Of Administration: Injectable, Oral, Other Modes Of Action
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-users Subsegments: 1) By Anticoagulants: Direct Oral Anticoagulants (DOACs), Vitamin K Antagonists, Low Molecular Weight Heparins, Unfractionated Heparin
2) By Inferior Vena Cava Filters: Retrievable IVC Filters, Permanent IVC Filters, Advanced IVC Filter Systems
3) By Other Drug Class: Thrombolytics, Antiplatelet Agents, Fibrinolytics, Combination Therapy
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Abbott Laboratories, Bristol-Myers Squibb Company, Sanofi-Aventis U.S. LLC, Daiichi Sankyo Company Limited, Aspen Pharmacare Holdings Limited, Novartis AG, Mylan N.V., Bayer AG, Boehringer Ingelheim GmbH, Medtronic PLC, Hikma Pharmaceuticals PLC, Laboratorios Farmacéuticos Rovi S.A., Cardinal Health Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca PLC, Stryker Corporation, Cook Medical Incorporated, Boston Scientific Corporation, Arjo AB, DJO Global Inc., Zimmer Biomet Holdings Inc., Devon Medical Products LLC, ThermoTek USA Inc., Pfizer Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Deep Vein Thrombosis Market Characteristics

3. Deep Vein Thrombosis Market Trends And Strategies

4. Deep Vein Thrombosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Deep Vein Thrombosis Growth Analysis And Strategic Analysis Framework

5.1. Global Deep Vein Thrombosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Deep Vein Thrombosis Market Growth Rate Analysis

5.4. Global Deep Vein Thrombosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Deep Vein Thrombosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Deep Vein Thrombosis Total Addressable Market (TAM)

6. Deep Vein Thrombosis Market Segmentation

6.1. Global Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Anticoagulants

Inferior Vena Cava Filters

Other Drug Class

6.2. Global Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Surgery

Drugs

Other Treatments

6.3. Global Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Injectable

Oral

Other Modes Of Action

6.4. Global Deep Vein Thrombosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

6.5. Global Deep Vein Thrombosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Homecare

Specialty Clinics

Other End-users

6.6. Global Deep Vein Thrombosis Market, Sub-Segmentation Of Anticoagulants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Direct Oral Anticoagulants (DOACs)

Vitamin K Antagonists

Low Molecular Weight Heparins

Unfractionated Heparin

6.7. Global Deep Vein Thrombosis Market, Sub-Segmentation Of Inferior Vena Cava Filters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Retrievable IVC Filters

Permanent IVC Filters

Advanced IVC Filter Systems

6.8. Global Deep Vein Thrombosis Market, Sub-Segmentation Of Other Drug Class, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Thrombolytics

Antiplatelet Agents

Fibrinolytics

Combination Therapy

7. Deep Vein Thrombosis Market Regional And Country Analysis

7.1. Global Deep Vein Thrombosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Deep Vein Thrombosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Deep Vein Thrombosis Market

8.1. Asia-Pacific Deep Vein Thrombosis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Deep Vein Thrombosis Market

9.1. China Deep Vein Thrombosis Market Overview

9.2. China Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Deep Vein Thrombosis Market

10.1. India Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Deep Vein Thrombosis Market

11.1. Japan Deep Vein Thrombosis Market Overview

11.2. Japan Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Deep Vein Thrombosis Market

12.1. Australia Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Deep Vein Thrombosis Market

13.1. Indonesia Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Deep Vein Thrombosis Market

14.1. South Korea Deep Vein Thrombosis Market Overview

14.2. South Korea Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Deep Vein Thrombosis Market

15.1. Western Europe Deep Vein Thrombosis Market Overview

15.2. Western Europe Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Deep Vein Thrombosis Market

16.1. UK Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Deep Vein Thrombosis Market

17.1. Germany Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Deep Vein Thrombosis Market

18.1. France Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Deep Vein Thrombosis Market

19.1. Italy Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Deep Vein Thrombosis Market

20.1. Spain Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Deep Vein Thrombosis Market

21.1. Eastern Europe Deep Vein Thrombosis Market Overview

21.2. Eastern Europe Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Deep Vein Thrombosis Market

22.1. Russia Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Deep Vein Thrombosis Market

23.1. North America Deep Vein Thrombosis Market Overview

23.2. North America Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Deep Vein Thrombosis Market

24.1. USA Deep Vein Thrombosis Market Overview

24.2. USA Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Deep Vein Thrombosis Market

25.1. Canada Deep Vein Thrombosis Market Overview

25.2. Canada Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Deep Vein Thrombosis Market

26.1. South America Deep Vein Thrombosis Market Overview

26.2. South America Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Deep Vein Thrombosis Market

27.1. Brazil Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Deep Vein Thrombosis Market

28.1. Middle East Deep Vein Thrombosis Market Overview

28.2. Middle East Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Deep Vein Thrombosis Market

29.1. Africa Deep Vein Thrombosis Market Overview

29.2. Africa Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Deep Vein Thrombosis Market Competitive Landscape And Company Profiles

30.1. Deep Vein Thrombosis Market Competitive Landscape

30.2. Deep Vein Thrombosis Market Company Profiles

30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Sanofi-Aventis U.S. LLC Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Daiichi Sankyo Company Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Aspen Pharmacare Holdings Limited Overview, Products and Services, Strategy and Financial Analysis

31. Deep Vein Thrombosis Market Other Major And Innovative Companies

31.1. Novartis AG

31.2. Mylan N.V.

31.3. Bayer AG

31.4. Boehringer Ingelheim GmbH

31.5. Medtronic PLC

31.6. Hikma Pharmaceuticals PLC

31.7. Laboratorios Farmacéuticos Rovi S.A.

31.8. Cardinal Health Inc.

31.9. Teva Pharmaceutical Industries Ltd.

31.10. AstraZeneca PLC

31.11. Stryker Corporation

31.12. Cook Medical Incorporated

31.13. Boston Scientific Corporation

31.14. Arjo AB

31.15. DJO Global Inc.

32. Global Deep Vein Thrombosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Deep Vein Thrombosis Market

34. Recent Developments In The Deep Vein Thrombosis Market

35. Deep Vein Thrombosis Market High Potential Countries, Segments and Strategies

35.1 Deep Vein Thrombosis Market In 2029 - Countries Offering Most New Opportunities

35.2 Deep Vein Thrombosis Market In 2029 - Segments Offering Most New Opportunities

35.3 Deep Vein Thrombosis Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Deep Vein Thrombosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Deep Vein Thrombosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Deep Vein Thrombosis Market, Sub-Segmentation Of Anticoagulants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Deep Vein Thrombosis Market, Sub-Segmentation Of Inferior Vena Cava Filters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Deep Vein Thrombosis Market, Sub-Segmentation Of Other Drug Class, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Deep Vein Thrombosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Deep Vein Thrombosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Abbott Laboratories Financial Performance
  • Table 80: Bristol-Myers Squibb Company Financial Performance
  • Table 81: Sanofi-Aventis U.S. LLC Financial Performance
  • Table 82: Daiichi Sankyo Company Limited Financial Performance
  • Table 83: Aspen Pharmacare Holdings Limited Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Deep Vein Thrombosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Deep Vein Thrombosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Deep Vein Thrombosis Market, Sub-Segmentation Of Anticoagulants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Deep Vein Thrombosis Market, Sub-Segmentation Of Inferior Vena Cava Filters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Deep Vein Thrombosis Market, Sub-Segmentation Of Other Drug Class, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Deep Vein Thrombosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Deep Vein Thrombosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Abbott Laboratories Financial Performance
  • Figure 80: Bristol-Myers Squibb Company Financial Performance
  • Figure 81: Sanofi-Aventis U.S. LLC Financial Performance
  • Figure 82: Daiichi Sankyo Company Limited Financial Performance
  • Figure 83: Aspen Pharmacare Holdings Limited Financial Performance

Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Read More About Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Projected to Reach $47.74 Billion by 2029 at a CAGR of 30.7%

Read More About Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Projected to Reach $47.74 Billion by 2029 at a CAGR of 30.7%

$8.21 Billion Forecast for Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market by 2029, Backed by Demand and Innovation

Read More About $8.21 Billion Forecast for Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market by 2029, Backed by Demand and Innovation

Fentanyl Market Forecast Reaching $22.03 Billion by 2029 at 6.5% CAGR

Read More About Fentanyl Market Forecast Reaching $22.03 Billion by 2029 at 6.5% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Read More About A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Deep Vein Thrombosis Global Market Report 2025 – By Drug Class (Anticoagulants, Inferior Vena Cava Filters, Other Drug Class), By Treatment (Surgery, Drugs, Other Treatments), By Mode Of Administration (Injectable, Oral,...

View Report

Venous Thromboembolism Global Market Report 2025 – By Type (Deep Vein Thrombosis, Pulmonary Embolism, Other Types), By Treatment (Anti-Clotting Medications,  Mechanical Devices, Thrombolytic Therapy, Other Treatment), By...

View Report

Thrombophilia Global Market Report 2025 – By Type (Factor V Leiden, Prothrombin 20210, Antiphospholipid Syndrome, Other Type), By Drugs (Heparin, Warfarin, Other Drugs), By Route Of Administration (Oral, Parenteral, Othe...

View Report

Vein Illuminator Global Market Report 2025 – By Technology (Near-Infrared Illumination, Transillumination, Ultrasound Technologies), By Application (Intravenous Access, Blood Draw, Other Applications), By End User (Hospi...

View Report

Vascular Embolization Global Market Report 2025 – By Product (Embolic Agents, Embolization Devices), By Embolization Technique (Coiling Devices, Non-Coiling Devices), By Application (Peripheral Vascular Diseases, Oncolog...

View Report

Pulmonary Embolism Global Market Report 2025 – By Treatment (Medications, Mechanical Devices, Other Treatments), By Diagnosis (Chest X-Ray, Electrocardiogram (ECG), Magnetic Resonance Imaging (MRI), Computed Tomography S...

View Report

Thrombectomy Devices Global Market Report 2025 – By Product Type (Aspiration Thrombectomy Devices, Mechanical Thrombectomy Devices, Ultrasonic Thrombectomy Devices, Other Product Types), By Application (Cardiovascular Ap...

View Report

Antithrombotic Drugs Market - By Type Of Product (Anticoagulant Drugs, Antiplatelet Drugs, Thrombolytic Drugs), By Application (Blood Clot And Thromboembolic Treatment, Hyperlipidemia Treatment, Prophylactic Treatment, O...

View Report

Frequently Asked Questions

Deep vein thrombosis (DVT) refers to a serious medical condition that occurs when a blood clot forms in one or more of the deep veins in the body. The symptoms of DVT can include swelling, pain, and tenderness in the affected area, usually the leg. For further insights on this market, request a sample here

The market major growth driver - Rising Demand For Deep Vein Thrombosis (DVT) Treatment Drives Market Growth. For further insights on this market, request a sample here

The deep vein thrombosis market size has grown steadily in recent years. It will grow from $1.06 billion in 2024 to $1.09 billion in 2025 at a compound annual growth rate (CAGR) of 3.1%. The growth in the historic period can be attributed to increased vascular medicine specialization, influence of medical guidelines, focus on thrombosis prevention, clinical research development, increased diagnosis awareness The deep vein thrombosis market size is expected to see steady growth in the next few years. It will grow to " $1.3 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to growing aging population, rising incidence of lifestyle diseases, preventive healthcare emphasis, innovative therapies, focus on patient-centric care. Major trends in the forecast period include risk factors awareness, advancements in diagnosis, treatment innovations, public health initiatives, post-surgical prevention. For further insights on this market, request a sample here

The deep vein thrombosis market covered in this report is segmented –
1) By Drug Class: Anticoagulants, Inferior Vena Cava Filters, Other Drug Class
2) By Treatment: Surgery, Drugs, Other Treatments
3) By Mode Of Administration: Injectable, Oral, Other Modes Of Action
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-users Subsegments:
1) By Anticoagulants: Direct Oral Anticoagulants (DOACs), Vitamin K Antagonists, Low Molecular Weight Heparins, Unfractionated Heparin
2) By Inferior Vena Cava Filters: Retrievable IVC Filters, Permanent IVC Filters, Advanced IVC Filter Systems
3) By Other Drug Class: Thrombolytics, Antiplatelet Agents, Fibrinolytics, Combination Therapy For further insights on this market, request a sample here

North America was the largest region in the deep vein thrombosis market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global deep vein thrombosis market report during the forecast period. The regions covered in the deep vein thrombosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the deep vein thrombosis market include Abbott Laboratories, Bristol-Myers Squibb Company, Sanofi-Aventis U.S. LLC, Daiichi Sankyo Company Limited, Aspen Pharmacare Holdings Limited, Novartis AG, Mylan N.V., Bayer AG, Boehringer Ingelheim GmbH, Medtronic PLC, Hikma Pharmaceuticals PLC, Laboratorios Farmacéuticos Rovi S.A., Cardinal Health Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca PLC, Stryker Corporation, Cook Medical Incorporated, Boston Scientific Corporation, Arjo AB, DJO Global Inc., Zimmer Biomet Holdings Inc., Devon Medical Products LLC, ThermoTek USA Inc., Pfizer Inc. . For further insights on this market, request a sample here.

Major trends in this market include Companies Unveil Revolutionary Mechanical Thrombectomy System With Lightning Flash Technology To Driving Innovations In Deep Vein Thrombosis Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Deep Vein Thrombosis Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon